1471256-75-3

Upstream product

• 4186-49-6 2-bromo-6-methyl-4-nitrophenol 
• 99-53-6 2-methyl-4-nitrophenol 
• 1403666-47-6 2-bromo-6-methyl-4-nitrophenyl trifluoromethanesulfonate 
• 1403666-48-7 1-bromo-3-methyl-5-nitro-2-vinylbenzene 
• 1403666-49-8 (S)-1-(2-bromo-6-methyl-4-nitrophenyl)ethane-1,2-diol 
• 1403666-50-1 (S)-2-(2-bromo-6-methyl-4-nitrophenyl)-2-hydroxyethyl pivalate 
• 1403666-51-2 (S)-2-(2-bromo-6-methyl-4-nitrophenyl)-2-tert-butoxyethyl pivalate 
• 1403666-52-3 (S)-2-(4-amino-2-bromo-6-methylphenyl)-2-tert-butoxyethyl pivalate 
• 1470310-66-7 (S)-2-(2-amino-7-(4-chlorophenyl)-5-methylbenzo[d]thiazol-6-yl)-2-tert-butoxyethyl pivalate 
• 1470311-08-0 (S)-2-(2-bromo-7-(4-chlorophenyl)-5-methylbenzo[d]thiazol-6-yl)-2-tert-butoxyethyl pivalate 
• 74-88-4 methyl iodide 

Downstream Products

• 1471250-15-3 (S)-2-tert-butoxy-2-(7-(4-chlorophenyl)-5-methyl-2-(1-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)benzo[d]thiazol-6-yl)acetic acid 
• 1471256-76-4 (S)-2-tert-butoxy-2-(7-(4-chlorophenyl)-5-methyl-2-(1-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)benzo[d]thiazol-6-yl)ethanol 

Relevant academic research and scientific papers

THERAPEUTIC COMPOUNDS

Compounds disclosed herein including compounds of formula I′: and salts thereof are provided. Pharmaceutical compositions comprising compounds disclosed herein, processes for preparing compounds disclosed herein, intermediates useful for preparing compounds disclosed herein and therapeutic methods for treating an HIV infection using compounds disclosed herein are also provided.